Pharmaceutical Accountability Foundation
33 posts
@PharmAccFound
the Pharmaceutical Accountability Foundation is the English international account of the Dutch non-profit Stichting Farma ter Verantwoording @StichtingFTV
European legislation designed to help patients with rare diseases has yielded lucrative results for the drug industry, finds a new investigation published in @bmj_latest and the Dutch Journal of Medicine ow.ly/YIrg50AKqUz
De ACM verlengt het onderzoek naar het weesgeneesmiddel CDCA van fabrikant Leadiant: acm.nl/nl/publicaties…
De ACM verlengt het onderzoek naar het weesgeneesmiddel CDCA van fabrikant Leadiant: acm.nl/nl/publicaties…
New @SOMO research reveals Big Pharma’s business model has shifted radically since 2000, with more investment in financial activities than in R&D for new drugs. This leaves the sector vulnerable in times of crisis, with potentially high costs for society. somo.nu/3egg5wR
Proud of my colleagues @EelkeA and @janheinstrop for exposing the failed monopoly strategy of Roche: keeping a crucial recipe for #coronatesting for themselves. Open source in the pharmaceutical industry is still underdeveloped. #timeforchange @FTM_nl ftm.nl/artikelen/roch…
Lupin has increased the price of mexiletine from €450 to €85000/patient/year. Cardiology patients now need off-label prescriptions of an excessively priced orphan drug! Continued misuse of orphan drug legislation: a life-threatening risk for mexiletine. doi.org/10.1093/eurhea…
